Quavonlimab (Anti-CTLA-4 / CD152)

Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

• Supplier: Selleck Chemicals
• Product #: A3020
• Sku #: A3020-1mg